drugset / Trial / NCT03721406
Pharmacokinetic of Thoracic Paravertebral Ropivacaine
NaSingle-groupOpen-labelBasic science
Summary
The study aims to investigate the pharmacokinetic of ropivacaine in patients undergoing ultrasound guided thoracic paravertebral block (TPVB) both after a single-bolus injection via the thoracic paravertebral catheter given before the start of surgery and after continuous thoracic paravertebral infusion that will start after the end of the procedure in order to achieve postoperative analgesia after open thoracotomy during the first 3 postoperative days
Timeline
- Start
- 2019-10-08
- Primary completion
- 2021-10-25
- Completion
- 2021-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropivacaine | Other / unclassified | 14 ml | Other |
Indications
No indication recorded.